I found that so many people were making their own GLP-1s and taking smaller amounts than normally prescribed,” she said. “I ...

A new technology is disrupting the economy. Even experts don’t entirely understand how it works, its full range of uses and ...

We recently compiled a list of the 10 Best Diabetes Stocks To Buy Under $10. In this article, we are going to take a look at ...

About 422 million people worldwide have diabetes, according to the WHO, and most of them live in low- or middle-income ...

Let’s begin by celebrating the man whose year is only going to go downhill from here.

Life expectancy in 2023 rose 0.9 years to 78.4 while the overall mortality rate adjusted for age declined 6%. Death rates ...

Life expectancy in the U.S. last year made an unusually sharp increase as deaths from most major causes declined, according to the ...

It’s that time of year when looking in the mirror is even more painful than usual. Every mince pie, every chocolate truffle, ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

The following editorial appeared in The Wall Street Journal. It does not necessarily reflect the opinion of The Tribune- Democrat.

Americans can expect more longevity gains in the future —as long as Washington doesn’t introduce harmful policies.

GLP-1 agonists like Ozempic effectively help manage obesity, but quitting the medication can lead to a resurgence in weight and related health issues. Gradual cessation is advised to avoid sudden ...